← All claims

Supplements · Metabolic & Cardiometabolic

creatine prevents cancer

In plain terms: Does creatine fight cancer?

Leans against Supplements 🐭 Non-human evidence🔬 Includes disconfirming

Part of: 🧪 creatine

RefutedContestedStrong support
consensus score -0.44

The evidence leans the other way. In animal studies creatine has actually promoted cancer spread, and blocking it slowed colon cancer — the opposite of 'anti-cancer.' Its role is complex and unproven in humans, and there's no basis to take it to prevent cancer.

📅 Last reviewed: 2026-07-14

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: Animal studies (Animal)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

1 support 6 contradict 1 tested null 4 mixed · 12 sources, 7 independent groups

What the evidence shows

Claimed as 'anti-cancer properties' — the preclinical reality is the opposite-leaning and mixed: mouse studies show creatine can promote cancer metastasis (Smad2/3), and blocking the creatine transporter suppresses colon-cancer growth. Reviews describe dual, context-dependent roles. No human evidence of cancer prevention exists — graded leans-against.

The evidence (12)

SourceGradeStanceQualityFinding
Demir M et al
2026 · study_type: in-vitro
in-vitro contradicts moderate Mitochondrial creatine kinase (MtCK) is overexpressed in many cancer cells to meet energy demand and linked to poor prognosis; authors develop small-molecule inhibitors of MtCK as a breast-cancer therapeutic strategy.
Bao W et al
2026 · study_type: animal
animal contradicts moderate SLC6A8 (creatine transporter) is upregulated in hepatocellular carcinoma and associated with poor prognosis; genetic/pharmacological SLC6A8 blockade (RGX-202) suppressed HCC tumor growth in vitro and in xenograft mice, enhancing ferroptosis
Wang JD et al
2026 · study_type: mechanism
mechanism contradicts moderate In NPM1-mutant AML, FTO-driven creatine anabolism promotes macrophage M2 polarization (pro-tumor immunosuppressive phenotype), described as playing an 'oncogenic role.'
Rao L et al
2025 · study_type: observational
observational tested-null moderate Retrospective cohort (n=1,651) found platelet-derived creatine-kinase isoenzymes (CKB, mitochondrial CK) drive paradoxical serum CK-MB elevations in cancer patients, with CKB expression enriched specifically in metastatic tumor cells.
Zhang
2022 · Trends Cell Biol
observational mixed low Review: creatine has dual, context-dependent roles in cancer — both anti-tumor and pro-tumor mechanisms are reported.
Kang E et al
2026 · study_type: animal
animal supports moderate Creatine transporter (CrT) upregulation and creatine supplementation enhanced mouse and human dendritic-cell activation, boosting antigen-specific CD8 T-cell responses, and creatine supplementation suppressed tumor growth in a syngeneic mel
Zhang
2021 · Cell Metab
animal contradicts moderate Orthotopic mouse models: creatine PROMOTED cancer metastasis via Smad2/3 — an adverse, not protective, effect.
Shin J et al
2026 · study_type: animal
animal mixed moderate Systematic review of 5 preclinical studies: creatine supplementation combined with PD-1 blockade improved T-cell/macrophage-driven antitumor immunity in some tumor models, but conflicting reports show creatine-associated metastasis in selec
Wang K et al
2026 · study_type: mechanism
mechanism contradicts moderate Review notes SLC6A8 (creatine transporter) is aberrantly overexpressed across many cancers, and that INHIBITING it (RGX-202/ompenaclid) shows broad antitumor activity in preclinical colorectal/hepatocellular models.
Longobardi I et al
2025 · study_type: meta-analysis
observational mixed low Narrative safety review states that although creatine has theoretical potential to form carcinogenic compounds, current evidence does not support a link between creatine supplementation and cancer risk.
Kurth
2021 · Sci Adv
animal contradicts moderate Animal study: inhibiting the SLC6A8 creatine transporter suppressed colon-cancer progression, implying creatine availability supports tumor growth.
Kazak
2020 · Nat Rev Endocrinol
observational mixed low Review: creatine metabolism has complex roles in immunity and cancer biology; not a clean anti-cancer agent.

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.